Myelodysplastic的例句大全

Objective To advance laboratory diagnose level and criterion character of myelodysplastic syndrome ( MDS).

目的：提高骨髓增生异常综合征（MDS）的实验室诊断水平及规范性。

Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes

白血病和骨髓增生异常综合征患者红细胞酶及同工酶谱的改变

The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes

骨髓增生异常综合征造血细胞生物学指标检测的意义

Quantitative study of calcitonin gene methylation in myelodysplastic syndromes

骨髓增生异常综合征降钙素基因甲基化的定量研究

Prospective study on the multi-parameter diagnosis for myelodysplastic syndromes

骨髓增生异常综合征多指标综合诊断的前瞻性研究

Objective To study the origin and progress of myelodysplastic syndrome with hypoplasia.

目的探讨低增生骨髓增生异常综合征的由来和发展。

Morphological changes of detrusor in myelodysplastic bladder and its clinical significance

脊髓发育不良性膀胱逼尿肌形态学改变及临床意义

Study on Karyotype of 306 Cases of Myelodysplastic Syndrome

306例骨髓增生异常综合征染色体核型的研究

Myelodysplastic syndrome: a histochemical study in 38 cases

骨髓增生异常综合征（3）38例组织化学染色分析

Clinical and morphology study of myelodysplastic syndrome ( MDS) changing into leukemia

向急性白血病转归的骨髓增生异常综合征临床与形态学研究

Evaluation on Morphological Markers for Diagnosis or Myelodysplastic Syndrome

骨髓异常增生综合征6项发育异常形态学诊断指标的评价

Clinical Observation of Treatment of Myelodysplastic Syndrome with rIFN-γ

γ-基因工程干扰素治疗骨髓增生异常综合征的临床研究

Telomerase activity in myelodysplastic syndrome Clinic Study on Myelodysplastic Syndrome

骨髓增生异常综合征的骨髓细胞端粒酶活性研究（英文）骨髓增生异常综合征54例临床分析

Observation on the patients with myelodysplastic syndrome by triad therapy

三联疗法治疗骨髓增生异常综合征难治性贫血疗效观察

Objective To study the clinical features, laboratory index and therapy of hypoplastic myelodysplastic syndrome.

目的探讨低增生性骨髓增生异常综合征（hypo-MDS）的临床特征、实验室指标及治疗。

Analysis of forty cases of myelodysplastic syndrome

骨髓增生异常综合征41例分析

Bone marrow pathological observation of hypoplastic myelodysplastic syndrome

低增生型骨髓增生异常综合征的骨髓病理观察

Objective: observation on jianpi bushen recipe combined with stanozolol in the treatment of Myelodysplastic syndromes-RA ( myelodysplastic syndrome, MDS-RA) clinical effects, and a preliminary study on the therapeutic mechanism, to provide a basis for clinical use of drugs.

目的：观察以健脾补肾方药为主联合康力龙治疗骨髓增生异常综合征RA型（Myelodysplastic syndrome，MDS-RA）的临床疗效，并初步探讨其疗效机理，为临床用药提供依据。

Follow-up was complete in 23 patients, among which, 10 patients were cured, 1 patient died of intracerebral hemorrhage, 2 patients progressed to aplastic anemia ( AA), 1 patient progressed to myelodysplastic syndrome ( MDS).

在23例病人中，10例治疗有效，1例因颅内出血死亡，2例转化为再生障碍性贫血，1例转化为骨髓增生异常综合征。

Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP

DNA末端原位标记结合免疫酶标技术研究骨髓增生异常综合征原位细胞凋亡